MarketWatch News on RNN
Rexahn prices offering at 30% discount 10:58 a.m. Nov. 29, 2012 - MarketWatch.com
AEterna falls; Inspire, Rexahn rally 2:15 p.m. April 16, 2010 - Val Brickates Kennedy
Javelin rockets, Myriad gains on scrapped merger 12:20 p.m. April 12, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:26 p.m. April 7, 2010 - MarketWatch
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Letter up 230% last year without trading 3:00 a.m. Jan. 11, 2010 - Peter Brimelow
Advertisement
Other News on RNN
10-Q: REXAHN PHARMACEUTICALS, INC. 4:35 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn's New Nanotechnology Patent Creates Next-Generation Docetaxel, Gemcitabine And Cisplatin 9:01 a.m. Oct. 7, 2014 - Seeking Alpha
Rexahn Pharmaceuticals (RNN) Jumps: Stock Gains 10.2% - Tale of the Tape 8:25 a.m. Sept. 26, 2014 - Zacks.com
Rexahn Update: A Partnership Is All The More Likely 12:13 p.m. Sept. 25, 2014 - Seeking Alpha
Rexahn +7.9% AH after RX-3117 receives orphan status 4:55 p.m. Sept. 24, 2014 - Seeking Alpha
Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 9.6% - Tale of the Tape 8:39 a.m. Sept. 4, 2014 - Zacks.com
Rexahn receives NOA for drug delivery platform patent 12:40 p.m. Sept. 3, 2014 - Seeking Alpha
Update: Rexahn Q2 Earnings - Stock Down, But My Optimism Remains Intact 12:14 a.m. Aug. 15, 2014 - Seeking Alpha
10-Q: REXAHN PHARMACEUTICALS, INC. 6:39 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn provides update on Supinoxin trial 8:30 a.m. July 18, 2014 - Seeking Alpha
What Falling Estimates & Price Mean for Rexahn Pharmaceuticals (RNN) - Tale of the Tape 7:45 a.m. June 16, 2014 - Zacks.com
Rexahn Pharmaceuticals (RNN) Jumps: Stock Surges 19.2% - Tale of the Tape 8:46 a.m. May 16, 2014 - Zacks.com
More on Rexahn Q1 results and pipeline update 10:42 a.m. May 15, 2014 - Seeking Alpha
10-Q: REXAHN PHARMACEUTICALS, INC. 4:10 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn Pharmaceuticals: An Undervalued Oncology Play With Risk Diversification 4:07 p.m. May 14, 2014 - Seeking Alpha
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff 3:23 p.m. April 21, 2014 - Seeking Alpha
10-K: REXAHN PHARMACEUTICALS, INC. 3:21 p.m. March 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Phase I Data on Rexahn's Supinoxin - Analyst Blog 4:30 p.m. March 12, 2014 - Zacks.com
Rexahn Pharma up 10% 12:26 p.m. March 11, 2014 - Seeking Alpha
Rexahn cancer drug safe so far in Phase I study, shares jump 7:33 a.m. March 11, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on RNN
Rexahn Pharmaceuticals Reports Third Quarter 2014 Financial Results and Pipeline Update 9:01 a.m. Nov. 13, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the Stifel 2014 Healthcare Conference on November 18, 2014 9:01 a.m. Nov. 11, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the BIO-Europe(R) Conference in Frankfurt, Germany 8:01 a.m. Oct. 28, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at 13th Annual BIO Investor Forum 8:00 a.m. Sept. 30, 2014 - GlobeNewswire
Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma, Cytori Therapeutics, Alnylam Pharma, and Rexahn Pharma 8:00 a.m. Sept. 25, 2014 - PR Newswire - PRF
Rexahn Receives FDA Orphan Drug Designation for RX-3117 in Treatment of Pancreatic Cancer 3:31 p.m. Sept. 24, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the 14th Annual Biotech in Europe Investor Forum for Global Partnering and Investment in Basel, Switzerland 8:01 a.m. Sept. 23, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the BioPharm America™ 2014 in Boston, Massachusetts, USA 8:02 a.m. Sept. 16, 2014 - BusinessWire - BZX
Rexahn Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference on September 9,2014 8:00 a.m. Sept. 4, 2014 - BusinessWire - BZX
Rexahn Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Novel Targeted Cancer Drug Delivery Platform 8:01 a.m. Sept. 3, 2014 - BusinessWire - BZX
Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte 8:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024 12:22 p.m. Aug. 19, 2014 - PR Newswire - PRF
Rexahn Pharmaceuticals Reports Second Quarter 2014 Financial Results and Pipeline Update 8:01 a.m. Aug. 14, 2014 - BusinessWire - BZX
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors 8:01 a.m. July 18, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 6:10 a.m. May 30, 2014 - PR Newswire - PRF
Three biotechs stocks with positive institutional transactions, good price to cash ratios and "buy" recommendations from street analysts 7:09 a.m. May 22, 2014 - ACCESSWIRE
Pharmaceutical Development & Medical Cannabis Expand at an Aggressive Rate - Company Attracts Major Attention at WebCongress Conference in San Francisco 8:20 a.m. May 16, 2014 - PR Newswire - PRF
Rexahn Pharmaceuticals Reports First Quarter 2014 Financial Results and Pipeline Update 8:03 a.m. May 15, 2014 - BusinessWire - BZX
Rexahn Announces Additional Data from Preclinical Studies of RX-3117 8:02 a.m. May 8, 2014 - BusinessWire - BZX
Biotech Stocks Review -- Research on Retrophin, Merrimack, Gilead Sciences, and Rexahn Pharma 11:37 a.m. May 6, 2014 - PR Newswire - PRF
Loading more headlines...